🔎 Trials Near Me

Akèy › Gliyoblastòm › Texas › Dallas

Etid klinik pou Gliyoblastòm nan Dallas, TX

9 etid pou Gliyoblastòm ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Ap rekriteFaz 3
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05902169

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Ap rekriteFaz 1/2
  • The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
Jiska laj 25 · Tout sèks · Mizajou Sep 25, 2026 · NCT04094610

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Ap rekriteFaz 1/2
  • Baylor, Scott and White Research Institute, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06047379

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Ap rekriteFaz 3
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

Imaging Acetadote Metabolism in Glioblastoma

Ap rekriteFaz 1 bonè
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT07387666

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Dallas
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Ap rekriteFaz 1/2
  • Mary Crowley Cancer Research, Dallas
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2025 · NCT05941507

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

Ap rekriteFaz 1/2
  • UT Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Mar 26, 2025 · NCT01906385

Etid Gliyoblastòm nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.